170 related articles for article (PubMed ID: 22875468)
21. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
Demirel I; Säve S; Kruse R; Persson K
APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
[TBL] [Abstract][Full Text] [Related]
22. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
23. miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.
Collins AS; McCoy CE; Lloyd AT; O'Farrelly C; Stevenson NJ
PLoS One; 2013; 8(7):e69090. PubMed ID: 23894411
[TBL] [Abstract][Full Text] [Related]
24. CUEDC2 (CUE domain-containing 2) and SOCS3 (suppressors of cytokine signaling 3) cooperate to negatively regulate Janus kinase 1/signal transducers and activators of transcription 3 signaling.
Zhang WN; Wang L; Wang Q; Luo X; Fang DF; Chen Y; Pan X; Man JH; Xia Q; Jin BF; Li WH; Li T; Liang B; Chen L; Gong WL; Yu M; Li AL; Zhou T; Li HY
J Biol Chem; 2012 Jan; 287(1):382-392. PubMed ID: 22084247
[TBL] [Abstract][Full Text] [Related]
25. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.
Yasukawa H; Hoshijima M; Gu Y; Nakamura T; Pradervand S; Hanada T; Hanakawa Y; Yoshimura A; Ross J; Chien KR
J Clin Invest; 2001 Nov; 108(10):1459-67. PubMed ID: 11714737
[TBL] [Abstract][Full Text] [Related]
26. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.
Francipane MG; Eterno V; Spina V; Bini M; Scerrino G; Buscemi G; Gulotta G; Todaro M; Dieli F; De Maria R; Stassi G
Cancer Res; 2009 Aug; 69(15):6141-8. PubMed ID: 19638576
[TBL] [Abstract][Full Text] [Related]
27. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
28. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
29. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
[TBL] [Abstract][Full Text] [Related]
31. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
32. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
33. Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury.
Langdale LA; Hoagland V; Benz W; Riehle KJ; Campbell JS; Liggitt DH; Fausto N
J Hepatol; 2008 Aug; 49(2):198-206. PubMed ID: 18471922
[TBL] [Abstract][Full Text] [Related]
34. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis.
de Andrés MC; Imagawa K; Hashimoto K; Gonzalez A; Goldring MB; Roach HI; Oreffo RO
Biochem Biophys Res Commun; 2011 Apr; 407(1):54-9. PubMed ID: 21352802
[TBL] [Abstract][Full Text] [Related]
35. Cardiac-specific deletion of SOCS-3 prevents development of left ventricular remodeling after acute myocardial infarction.
Oba T; Yasukawa H; Hoshijima M; Sasaki K; Futamata N; Fukui D; Mawatari K; Nagata T; Kyogoku S; Ohshima H; Minami T; Nakamura K; Kang D; Yajima T; Knowlton KU; Imaizumi T
J Am Coll Cardiol; 2012 Feb; 59(9):838-52. PubMed ID: 22361405
[TBL] [Abstract][Full Text] [Related]
36. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling-3.
Bergamin E; Wu J; Hubbard SR
Structure; 2006 Aug; 14(8):1285-92. PubMed ID: 16905102
[TBL] [Abstract][Full Text] [Related]
38. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
Song MM; Shuai K
J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
[TBL] [Abstract][Full Text] [Related]
39. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.
Baus D; Pfitzner E
Int J Cancer; 2006 Mar; 118(6):1404-13. PubMed ID: 16206268
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
